MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+59.95%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$105M
AUM Growth
+$105M
(+9.5%)
Cap. Flow
-$6.44M
Cap. Flow
% of AUM
-6.14%
Top 10 Holdings %
Top 10 Hldgs %
95.3%
Holding
17
New
5
Increased
2
Reduced
4
Closed
3
Top Buys
| 1 |
Arrowhead Research
ARWR
|
$5.84M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$4.77M |
| 3 |
ProQR Therapeutics
PRQR
|
$3.36M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.86M |
| 5 |
SLN
Silence Therapeutics
SLN
|
$2.22M |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$14.6M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$4.27M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$3.01M |
| 4 |
TG Therapeutics
TGTX
|
$2.77M |
| 5 |
Leap Therapeutics
LPTX
|
$2.35M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $41.3M | 39.39% |
5,903,405
-2,078,799
| -26% | -$14.6M |
|
2
Rocket Pharmaceuticals
RCKT
$354M
| $14.1M | 13.47% |
722,080
+56,200
| +8% | +$1.1M |
|
3
Invivyd
IVVD
$204M
| $13.9M | 13.22% |
9,248,250
| – | – |
|
|
4
ProQR Therapeutics
PRQR
$237M
| $7.07M | 6.74% |
1,910,600
+908,800
| +91% | +$3.36M |
|
|
5
Arrowhead Research
ARWR
$3.05B
| $5.84M | 5.56% |
+143,900
| New | +$5.84M |
|
|
6
Ionis Pharmaceuticals
IONS
$6.79B
| $4.77M | 4.55% |
+126,300
| New | +$4.77M |
|
7
Stoke Therapeutics
STOK
$1.08B
| $4.46M | 4.25% |
482,890
-39,660
| -8% | -$366K |
|
8
BridgeBio Pharma
BBIO
$9.89B
| $3.19M | 3.04% |
419,000
-94,300
| -18% | -$719K |
|
|
SWTX
9
DELISTED
SpringWorks Therapeutics
SWTX
| $2.86M | 2.72% |
+109,900
| New | +$2.86M |
|
10
Curis
CRIS
$20.9M
| $2.47M | 2.35% |
4,482,142
| – | – |
|
|
SLN
11
Silence Therapeutics
SLN
$227M
| $2.22M | 2.12% |
+145,900
| New | +$2.22M |
|
12
Atara Biotherapeutics
ATRA
$84.6M
| $1.44M | 1.37% |
+439,300
| New | +$1.44M |
|
|
13
TG Therapeutics
TGTX
$4.65B
| $1.24M | 1.18% |
104,400
-234,400
| -69% | -$2.77M |
|
|
NEXI
14
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $32.4K | 0.03% |
133,442
| – | – |
|
|
15
Leap Therapeutics
LPTX
$12M
| – | – |
-2,664,400
| Closed | -$2.35M |
|
|
VERV
16
DELISTED
Verve Therapeutics
VERV
| – | – |
-87,600
| Closed | -$3.01M |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-61,200
| Closed | -$4.27M |
|